$GDRX
GoodRx Holdings, Inc. Stock $gdrx

$gdrx Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000095017023005262 Filed on March 01, 2023

Income Statement

Concept	2022 Q4	2022	2021
Revenue	$184.1M	$766.6M	$745.4M
YoY Change	-13.67%	2.83%	35.36%
Cost Of Revenue	$17.36M	$65.08M	$46.72M
YoY Change	24.65%	39.31%	57.82%
Gross Profit	$166.7M	$701.5M	$698.7M
YoY Change	-16.34%	0.4%	34.08%
Gross Profit Margin	90.57%	91.51%	93.73%
Selling, General & Admin	$109.9M	$502.4M	$524.9M
YoY Change	-22.57%	-4.28%	-26.75%
% of Gross Profit	65.88%	71.62%	75.12%
Research & Development	$36.77M	$143.1M	$125.9M
YoY Change	4.88%	13.73%	103.6%
% of Gross Profit	22.05%	20.41%	18.01%
Depreciation & Amortization	$15.53M	$4.600M	$4.000M
YoY Change	45.88%	15.0%	185.71%
% of Gross Profit	9.32%	0.66%	0.57%
Operating Expenses	$162.2M	$645.6M	$650.8M
YoY Change	-13.55%	-0.8%	-16.4%
Operating Profit	$4.593M	$1.738M	$13.41M
YoY Change	-60.93%	-87.04%	-104.86%
Interest Expense	-$6.482M	-$24.97M	-$23.58M
YoY Change	10.13%	5.88%	-15.17%
% of Operating Profit	-141.13%	-1436.65%	-175.91%
Other Income/Expense, Net		-$24.97M	-$23.58M
YoY Change		5.88%	-14.96%
Pretax Income	-$4.745M	-$23.23M	-$10.18M
YoY Change	-180.83%	128.27%	-96.65%
Income Tax	-$2.773M	$9.597M	$15.08M
% Of Pretax Income
Net Earnings	-$1.972M	-$32.83M	-$25.25M
YoY Change	-95.06%	29.99%	-91.4%
Net Earnings / Revenue	-1.07%	-4.28%	-3.39%
Basic Earnings Per Share		-$0.08	-$0.06
Diluted Earnings Per Share	$0.00	-$0.08	-$0.06
COMMON SHARES
Basic Shares Outstanding		412.9M	410.0M
Diluted Shares Outstanding		412.9M	410.0M

Balance Sheet

Concept	2022 Q4	2022	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$757.2M	$757.2M	$941.1M
YoY Change	-19.55%	-19.55%	-2.85%
Cash & Equivalents	$757.2M
Short-Term Investments
Other Short-Term Assets	$40.86M	$40.86M	$21.31M
YoY Change	91.75%	91.75%	4.45%
Inventory
Prepaid Expenses	$35.11M
Receivables	$117.1M	$117.1M	$118.1M
Other Receivables	$4.524M	$4.524M	$8.331M
Total Short-Term Assets	$919.7M	$919.7M	$1.089B
YoY Change	-15.53%	-15.53%	0.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$19.82M	$55.73M	$49.32M
YoY Change	-8.29%	13.0%	-2.92%
Goodwill	$412.1M
YoY Change	25.0%
Intangibles
YoY Change
Long-Term Investments	$19.00M
YoY Change	375.0%
Other Assets	$27.17M	$27.17M	$6.007M
YoY Change	352.22%	352.22%	-60.22%
Total Long-Term Assets	$684.9M	$684.9M	$518.8M
YoY Change	32.03%	32.03%	35.21%
TOTAL ASSETS
Total Short-Term Assets	$919.7M	$919.7M	$1.089B
Total Long-Term Assets	$684.9M	$684.9M	$518.8M
Total Assets	$1.605B	$1.605B	$1.608B
YoY Change	-0.19%	-0.19%	9.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.70M	$17.70M	$17.50M
YoY Change	1.14%	1.14%	69.91%
Accrued Expenses	$43.71M	$43.71M	$49.71M
YoY Change	-12.07%	-12.07%	40.44%
Deferred Revenue	$7.879M
YoY Change	14.19%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$7.029M	$7.029M	$7.029M
YoY Change	0.0%	0.0%	0.41%
Total Short-Term Liabilities	$76.32M	$76.32M	$81.11M
YoY Change	-5.91%	-5.91%	36.1%
LONG-TERM LIABILITIES
Long-Term Debt	$651.8M	$651.8M	$655.9M
YoY Change	-0.62%	-0.62%	-0.61%
Other Long-Term Liabilities	$7.557M	$61.69M	$38.73M
YoY Change	47.08%	59.28%	-1.45%
Total Long-Term Liabilities	$659.4M	$713.5M	$694.6M
YoY Change	-0.25%	2.72%	-0.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$76.32M	$76.32M	$81.11M
Total Long-Term Liabilities	$659.4M	$713.5M	$694.6M
Total Liabilities	$789.8M	$789.8M	$775.9M
YoY Change	1.79%	1.79%	2.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.449B
YoY Change	2.32%
Common Stock	$2.263B
YoY Change	0.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$814.8M	$814.8M	$831.7M
YoY Change
Total Liabilities & Shareholders Equity	$1.605B	$1.605B	$1.608B
YoY Change	-0.19%	-0.19%	9.35%

Cashflow Statement

Concept	2022 Q4	2022	2021
OPERATING ACTIVITIES
Net Income	-$1.972M	-$32.83M	-$25.25M
YoY Change	-95.06%	29.99%	-91.4%
Depreciation, Depletion And Amortization	$15.53M	$4.600M	$4.000M
YoY Change	45.88%	15.0%	185.71%
Cash From Operating Activities	$31.88M	$146.8M	$178.8M
YoY Change	-36.0%	-17.9%	36.12%
INVESTING ACTIVITIES
Capital Expenditures	$15.29M	$3.967M	$4.571M
YoY Change	-265.14%	-13.21%	-77.76%
Acquisitions		$156.9M	$140.3M
YoY Change		11.82%	151.41%
Other Investing Activities	$16.58M	-$155.3M	-$144.3M
YoY Change		7.63%	158.56%
Cash From Investing Activities	$1.286M	-$210.5M	-$178.7M
YoY Change	-113.89%	17.77%	95.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$101.7M	$0.00
YoY Change
Debt Paid & Issued, Net		$7.029M	$7.029M
YoY Change		0.0%	-79.93%
Cash From Financing Activities	-4.786M	-120.2M	-30.53M
YoY Change	-58.26%	293.82%	-103.37%
NET CHANGE
Cash From Operating Activities	31.88M	146.8M	178.8M
Cash From Investing Activities	1.286M	-210.5M	-178.7M
Cash From Financing Activities	-4.786M	-120.2M	-30.53M
Net Change In Cash	28.38M	-183.9M	30.48M
YoY Change	-2.43%	-703.45%	-96.78%
FREE CASH FLOW
Cash From Operating Activities	$31.88M	$146.8M	$178.8M
Capital Expenditures	$15.29M	$3.967M	$4.571M
Free Cash Flow	$16.59M	$142.8M	$174.2M
YoY Change	-71.92%	-18.02%	57.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	gdrx	Entity Incorporation Month And Year EntityIncorporationMonthAndYear	2015-09
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001809519
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39549
CY2022	dei	Entity Registrant Name EntityRegistrantName	GoodRx Holdings, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-5104396
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	2701 Olympic
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Boulevard
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Santa Monica
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90404
CY2022	dei	City Area Code CityAreaCode	855
CY2022	dei	Local Phone Number LocalPhoneNumber	268-2822
CY2022	dei	Security12b Title Security12bTitle	Class A common stock, $0.0001 par value
CY2022	dei	Trading Symbol TradingSymbol	GDRX
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6488000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	9910000
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	472100000
CY2022	dei	Auditor Firm AuditorFirmId	238
CY2022	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2022	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	757165000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	941109000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	117141000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	118080000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	45380000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	29638000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	919686000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1088827000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19820000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21612000
CY2022Q4	us-gaap	Goodwill Goodwill	412117000
CY2021Q4	us-gaap	Goodwill Goodwill	329696000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	119865000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	88791000
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	70072000
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	44987000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	35906000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	27705000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	27165000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6007000
CY2022Q4	us-gaap	Assets Assets	1604631000
CY2021Q4	us-gaap	Assets Assets	1607625000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	17700000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	17501000
CY2022Q4	gdrx	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	47523000
CY2021Q4	gdrx	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	50732000
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	7029000
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	7029000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4068000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5851000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	76320000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	81113000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	651796000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	655858000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	54131000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	33592000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7557000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5382000
CY2022Q4	us-gaap	Liabilities Liabilities	789804000
CY2021Q4	us-gaap	Liabilities Liabilities	775945000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	40000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	40000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2263322000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2247347000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1448535000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1415707000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	814827000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	831680000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1604631000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1607625000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	766554000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	745424000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	550700000
CY2022	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	65079000
CY2021	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	46716000
CY2020	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	29587000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	143137000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	125860000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	61816000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	357631000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	370217000
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	255135000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	144792000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	154686000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	461451000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	54177000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	34539000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18430000
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	764816000
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	732018000
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	826419000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	1738000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	13406000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-275719000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-22000
CY2022	us-gaap	Interest Income Other InterestIncomeOther	9274000
CY2021	us-gaap	Interest Income Other InterestIncomeOther	59000
CY2020	us-gaap	Interest Income Other InterestIncomeOther	160000
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	34243000
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	23642000
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	27913000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-24969000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-23583000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-27731000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23231000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10177000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-303450000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9597000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15077000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9827000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-32828000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-25254000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-293623000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.07
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.07
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	412858000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	412858000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	409981000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	409981000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	274696000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	274696000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-1087582000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10831000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	399722000
CY2020	gdrx	Temporary Equity Value Of Shares Converted TemporaryEquityValueOfSharesConverted	737009000
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	83575000
CY2020	gdrx	Stock Issued During Period Value Charitable Stock Donation StockIssuedDuringPeriodValueCharitableStockDonation	41721000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-293623000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	711359000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	35359000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	168171000
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	57955000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-25254000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	831680000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9128000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	129203000
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	20635000
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	101721000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-32828000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	814827000
CY2022	us-gaap	Profit Loss ProfitLoss	-32828000
CY2021	us-gaap	Profit Loss ProfitLoss	-25254000
CY2020	us-gaap	Profit Loss ProfitLoss	-293623000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	54177000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	34539000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18430000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3413000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3445000
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3390000
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	3349000
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	3102000
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	4478000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	120234000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	160462000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	397285000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	18057000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2068000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-497000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12851000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-10910000
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	11404000
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0
CY2020	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0
CY2022	gdrx	Loss On Abandonment And Impairment Of Operating Lease Assets LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets	12569000
CY2021	gdrx	Loss On Abandonment And Impairment Of Operating Lease Assets LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets	1430000
CY2020	gdrx	Loss On Abandonment And Impairment Of Operating Lease Assets LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets	961000
CY2022	gdrx	Charitable Stock Donation CharitableStockDonation	0
CY2021	gdrx	Charitable Stock Donation CharitableStockDonation	0
CY2020	gdrx	Charitable Stock Donation CharitableStockDonation	41721000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1375000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	43949000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16139000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	13644000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-17060000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	40935000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-874000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4207000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2154000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-5268000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	14001000
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	15010000
CY2022	gdrx	Increase Decrease Operating Lease Liabilities IncreaseDecreaseOperatingLeaseLiabilities	-4004000
CY2021	gdrx	Increase Decrease Operating Lease Liabilities IncreaseDecreaseOperatingLeaseLiabilities	-2404000
CY2020	gdrx	Increase Decrease Operating Lease Liabilities IncreaseDecreaseOperatingLeaseLiabilities	4576000
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2125000
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-711000
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2875000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	146780000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	178779000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	131341000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3967000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4571000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20553000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	156853000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	140268000
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	55793000
CY2022	us-gaap	Payments For Software PaymentsForSoftware	51247000
CY2021	us-gaap	Payments For Software PaymentsForSoftware	29886000
CY2020	us-gaap	Payments For Software PaymentsForSoftware	15271000
CY2022	gdrx	Investment In Minority Equity Interest InvestmentInMinorityEquityInterest	15007000
CY2021	gdrx	Investment In Minority Equity Interest InvestmentInMinorityEquityInterest	4008000
CY2020	gdrx	Investment In Minority Equity Interest InvestmentInMinorityEquityInterest	0
CY2022	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	16576000
CY2021	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0
CY2020	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-210498000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-178733000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-91617000
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0
CY2020	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	891793000
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0
CY2020	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	100000000
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	28000000
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7029000
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7029000
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	35029000
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1306000
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	832000
CY2020	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	101721000
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	4937000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9159000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	35021000
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5343000
CY2022	gdrx	Proceeds From Early Exercise Of Stock Options ProceedsFromEarlyExerciseOfStockOptions	0
CY2021	gdrx	Proceeds From Early Exercise Of Stock Options ProceedsFromEarlyExerciseOfStockOptions	0
CY2020	gdrx	Proceeds From Early Exercise Of Stock Options ProceedsFromEarlyExerciseOfStockOptions	667000
CY2022	gdrx	Employee Taxes Paid Related To Net Share Settlement Of Equity Awards EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards	20635000
CY2021	gdrx	Employee Taxes Paid Related To Net Share Settlement Of Equity Awards EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards	57688000
CY2020	gdrx	Employee Taxes Paid Related To Net Share Settlement Of Equity Awards EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards	78714000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-120226000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-30528000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	905817000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-183944000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30482000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	945541000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	941109000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	971591000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26050000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	757165000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	941109000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	971591000
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	4356000
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	18105000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	29228000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	30702000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	20198000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	24517000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	22491000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2910000
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	234000
CY2022	gdrx	Noncash Stock Based Compensation Included In Capitalized Software NoncashStockBasedCompensationIncludedInCapitalizedSoftware	8969000
CY2021	gdrx	Noncash Stock Based Compensation Included In Capitalized Software NoncashStockBasedCompensationIncludedInCapitalizedSoftware	7709000
CY2020	gdrx	Noncash Stock Based Compensation Included In Capitalized Software NoncashStockBasedCompensationIncludedInCapitalizedSoftware	2437000
CY2022	gdrx	Capitalized Software Included In Accounts Payable And Accrued Expenses And Other Current Liabilities CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities	4176000
CY2021	gdrx	Capitalized Software Included In Accounts Payable And Accrued Expenses And Other Current Liabilities CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities	1086000
CY2020	gdrx	Capitalized Software Included In Accounts Payable And Accrued Expenses And Other Current Liabilities CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities	1273000
CY2022	gdrx	Conversion Of Preferred Stock To Common Stock In Connection With Initial Public Offering ConversionOfPreferredStockToCommonStockInConnectionWithInitialPublicOffering	0
CY2021	gdrx	Conversion Of Preferred Stock To Common Stock In Connection With Initial Public Offering ConversionOfPreferredStockToCommonStockInConnectionWithInitialPublicOffering	0
CY2020	gdrx	Conversion Of Preferred Stock To Common Stock In Connection With Initial Public Offering ConversionOfPreferredStockToCommonStockInConnectionWithInitialPublicOffering	737009000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	757165000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	941109000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	968691000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	2900000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	757165000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	941109000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	971591000
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:1.867%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements, including the accompanying notes. We base our estimates on historical factors; current circumstances, including the impact of a grocery chain that previously did not accept discounted pricing for a subset of prescriptions drugs from our PBMs starting late in the first quarter of 2022 ("grocer issue"); macroeconomic events and conditions; consideration of the economic impact of COVID-19; and the experience and judgment of our management. We evaluate our estimates and assumptions on an ongoing basis. Actual results can differ materially from these estimates, and such differences can affect the results of operations reported in future periods. Although the grocer issue was addressed in August 2022 and our discounted pricing has since been consistently welcomed at the point of sale by the grocery chain, the sustained effects of the grocer issue on our business, future results of operations and financial condition continue to be difficult to estimate because there are several variables that are highly uncertain including, among others, consumer response to updated consumer pricing and timing and extent of returning user levels.</span></p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">Certain Risks and Concentrations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;"> </span></p><p style="text-indent:1.867%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash, cash equivalents and accounts receivable. We maintain cash deposits with multiple financial institutions in the United States which, at times, may exceed federally insured limits. Cash may be withdrawn or redeemed on demand. We believe that the financial institutions that hold our cash are financially sound and, accordingly, minimal credit risk exists with respect to these balances. We have not experienced any losses in such accounts.</span></p><p style="text-indent:1.867%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">We extend credit to our customers based on an evaluation of their ability to pay amounts due under contractual arrangements and generally do not obtain or require collateral.</span></p><p style="text-indent:1.867%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">For the year ended December 31, 2022, </span><span style="font-size:10.0pt;font-family:"Arial", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;"> customer accounted for </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">approximately </span><span style="font-size:10.0pt;font-family:"Arial", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">13</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;"> of our revenue. For the year ended December 31, 2021, </span><span style="font-size:10.0pt;font-family:"Arial", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;"> customers accounted for </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">approximately </span><span style="font-size:10.0pt;font-family:"Arial", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">13</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">% and </span><span style="font-size:10.0pt;font-family:"Arial", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">11</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;"> of our revenue. For the year ended December 31, 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:"Arial", sans-serif;white-space:pre-wrap;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">three</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;"> customers accounted for </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">approximately </span><span style="font-size:10.0pt;font-family:"Arial", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">17</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">%, </span><span style="font-size:10.0pt;font-family:"Arial", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">14</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">% and </span><span style="font-size:10.0pt;font-family:"Arial", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">11</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;"> of our revenue. At December 31, 2022, </span><span style="font-size:10.0pt;font-family:"Arial", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;"> customer accounted for </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">approximately </span><span style="font-size:10.0pt;font-family:"Arial", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">13</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;"> of our accounts receivable balance. At December 31, 2021, </span><span style="font-size:10.0pt;font-family:"Arial", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;"> customer accounted for more than </span><span style="font-size:10.0pt;font-family:"Arial", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;">% of our accounts receivable balance.</span></p>
CY2022	us-gaap	Property Plant And Equipment Depreciation Methods PropertyPlantAndEquipmentDepreciationMethods	Depreciation is computed using the straight-line method over the estimated useful lives of the assets
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	19000000.0
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	4000000.0
CY2022	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1
CY2020	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	550700000
CY2022	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	Certain of our leases contain renewal options for periods of up to ten years
CY2022Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P10Y
CY2022	us-gaap	Lessee Operating Lease Option To Terminate LesseeOperatingLeaseOptionToTerminate	early termination options by up to two years, at our election.
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	766554000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	745424000
CY2022	gdrx	Payment Due Conditions PaymentDueConditions	Payments are due generally within thirty to ninety days of invoice but may extend up to twelve months for a limited number of contracts.
CY2022	us-gaap	Advertising Expense AdvertisingExpense	226300000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	296600000
CY2020	us-gaap	Advertising Expense AdvertisingExpense	222400000
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	649600000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19820000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21612000
CY2022	us-gaap	Depreciation Depreciation	4600000
CY2021	us-gaap	Depreciation Depreciation	4000000.0
CY2020	us-gaap	Depreciation Depreciation	1400000
CY2022Q2	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	150000000.0
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	7000000.0
CY2022	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	10000000.0
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	7000000.0
CY2022Q4	gdrx	Capitalized Computer Software Expected Amortization Year Three CapitalizedComputerSoftwareExpectedAmortizationYearThree	8221000
CY2022Q4	gdrx	Capitalized Computer Software Expected Amortization CapitalizedComputerSoftwareExpectedAmortization	58853000
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	767125000
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	746299000
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-40901000
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-59400000
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	4524000
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	8331000
CY2022Q4	gdrx	Prepaid Software Implementation Costs PrepaidSoftwareImplementationCosts	5751000
CY2021Q4	gdrx	Prepaid Software Implementation Costs PrepaidSoftwareImplementationCosts	0
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	35105000
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	21307000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	45380000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	29638000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	29589000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	27441000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9769000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5829000
CY2021Q4	us-gaap	Goodwill Goodwill	329696000
CY2020Q4	us-gaap	Goodwill Goodwill	261116000
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	85560000
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	68580000
CY2022	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	3139000
CY2021	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	0
CY2022Q4	us-gaap	Goodwill Goodwill	412117000
CY2021Q4	us-gaap	Goodwill Goodwill	329696000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	208650000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	88785000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	119865000
CY2022	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P7Y10M24D
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	157114000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	68323000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	88791000
CY2021	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P8Y10M24D
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	23200000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	18300000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12700000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9242000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	21391000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	17039000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	15830000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	15427000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	10148000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	40030000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	119865000
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	109752000
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	63752000
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	39680000
CY2021Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	18765000
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	70072000
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	44987000
CY2022	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	26400000
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	12200000
CY2020	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	4400000
CY2022Q4	gdrx	Capitalized Software Costs Not Ready For Intended Use CapitalizedSoftwareCostsNotReadyForIntendedUse	11200000
CY2022Q4	gdrx	Capitalized Computer Software Expected Amortization Year One CapitalizedComputerSoftwareExpectedAmortizationYearOne	28743000
CY2022Q4	gdrx	Capitalized Computer Software Expected Amortization Year Two CapitalizedComputerSoftwareExpectedAmortizationYearTwo	21889000
CY2022Q4	gdrx	Accrued Bonus And Other Payroll Related Current AccruedBonusAndOtherPayrollRelatedCurrent	20642000
CY2021Q4	gdrx	Accrued Bonus And Other Payroll Related Current AccruedBonusAndOtherPayrollRelatedCurrent	24031000
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	12104000
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	15493000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7879000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6869000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6898000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4339000
CY2022Q4	gdrx	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	47523000
CY2021Q4	gdrx	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	50732000
CY2022	gdrx	Noncancellable Operating Lease Expiry Year NoncancellableOperatingLeaseExpiryYear	2033
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	6200000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	5600000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	7000000.0
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	6400000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	6200000
CY2021	gdrx	Lease Incentive Receivables Current LeaseIncentiveReceivablesCurrent	1600000
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	3000000.0
CY2020	gdrx	Lease Incentive Receivables Current LeaseIncentiveReceivablesCurrent	5700000
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y8M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.069
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.058
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4068000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	9430000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	43690000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	82828000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	24629000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	58199000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4068000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	54131000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	20200000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20200000
CY2022	us-gaap	Payments For Tenant Improvements PaymentsForTenantImprovements	3100000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	6974000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-361000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	235000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3120000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2532000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	848000
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	10094000
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	2171000
CY2020	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	1083000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-421000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	6521000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7472000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-76000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	6385000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3438000
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-497000
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	12906000
CY2020	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-10910000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9597000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15077000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9827000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4879000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2137000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-63725000
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2465000
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	8385000
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2768000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	383000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	491000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	609000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	4565000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-43797000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-19961000
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	6401000
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	8206000
CY2020	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	3541000
CY2022	gdrx	Income Tax Reconciliation Nondeductible Officers Compensation IncomeTaxReconciliationNondeductibleOfficersCompensation	12295000
CY2021	gdrx	Income Tax Reconciliation Nondeductible Officers Compensation IncomeTaxReconciliationNondeductibleOfficersCompensation	21905000
CY2020	gdrx	Income Tax Reconciliation Nondeductible Officers Compensation IncomeTaxReconciliationNondeductibleOfficersCompensation	79046000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	68000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	37782000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-293000
CY2022	gdrx	Effective Income Tax Rate Reconciliation Transaction Cost EffectiveIncomeTaxRateReconciliationTransactionCost	39000
CY2021	gdrx	Effective Income Tax Rate Reconciliation Transaction Cost EffectiveIncomeTaxRateReconciliationTransactionCost	438000
CY2020	gdrx	Effective Income Tax Rate Reconciliation Transaction Cost EffectiveIncomeTaxRateReconciliationTransactionCost	277000
CY2022	us-gaap	Income Tax Reconciliation Disposition Of Assets IncomeTaxReconciliationDispositionOfAssets	659000
CY2021	us-gaap	Income Tax Reconciliation Disposition Of Assets IncomeTaxReconciliationDispositionOfAssets	0
CY2020	us-gaap	Income Tax Reconciliation Disposition Of Assets IncomeTaxReconciliationDispositionOfAssets	0
CY2022	gdrx	Income Tax Reconciliation Nondeductible Penalties IncomeTaxReconciliationNondeductiblePenalties	318000
CY2021	gdrx	Income Tax Reconciliation Nondeductible Penalties IncomeTaxReconciliationNondeductiblePenalties	16000
CY2020	gdrx	Income Tax Reconciliation Nondeductible Penalties IncomeTaxReconciliationNondeductiblePenalties	6000
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	85000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	200000
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	523000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9597000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15077000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9827000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.413
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.481
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.032
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2703000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	5072000
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction	14402000
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction	9702000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	12542000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	10097000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	14382000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	19407000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	769000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	580000
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	4699000
CY2022Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	6810000
CY2021Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	8817000
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	10705000
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	8668000
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	9269000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8737000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	21907000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	80319000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	88949000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	57115000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	52679000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	23204000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	36270000
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1143000
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	527000
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	8815000
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	6727000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	4383000
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	4699000
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Software DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware	10926000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	9157000
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	13635000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	23498000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	36514000
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	294000
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	244000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	16900000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4374000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	126000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3327000
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	119000
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	317000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	7391000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	999000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	6911000
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	505000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	14796000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	422000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2444000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1160000
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1804000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	14698000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	14700000
CY2022Q4	gdrx	Unrecognized Tax Benefits Reduction To Deferred Tax Assets UnrecognizedTaxBenefitsReductionToDeferredTaxAssets	7400000
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	7300000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.41
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	18.81
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.23
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	18200000
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3000000.0
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3000000.0
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3000000.0
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	7029000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	7029000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	653010000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	667068000
CY2022	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2024-10-11
CY2021	gdrx	Line Of Credit Facility Fixed Fronting Fee Percentage LineOfCreditFacilityFixedFrontingFeePercentage	0.00125
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	0
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	0
CY2022Q4	gdrx	Purchase Commitment Amount Committed PurchaseCommitmentAmountCommitted	21300000
CY2022Q4	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	7100000
CY2021Q2	gdrx	Number Of Lawsuits NumberOfLawsuits	2
CY2022Q4	gdrx	Accrued Settlement AccruedSettlement	1500000
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000.0
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022	us-gaap	Common Stock Conversion Features CommonStockConversionFeatures	Each share of Class B common stock is convertible into one share of Class A common stock at any time at the option of the holder and will automatically convert to Class A common stock upon any transfer, except for certain permitted transfers. All Class B common stock will convert automatically into an equivalent number of Class A common stock upon the earlier of (i) September 25, 2027; or (ii) the first date the aggregate number of shares of Class B common stock cease to represent at least 10% of the aggregate outstanding shares of common stock. During the years ended December 31, 2022, 2021 and 2020, 1.8 million, 13.1 million and 28.7 million shares of Class B common stock were converted into an equivalent number of shares of Class A common stock, respectively.
CY2022	gdrx	Minimum Percentage Of Aggregate Outstanding Shares Of Common Stock To Be Cease MinimumPercentageOfAggregateOutstandingSharesOfCommonStockToBeCease	0.10
CY2020	gdrx	Stock Issued During Period Value Charitable Stock Donation StockIssuedDuringPeriodValueCharitableStockDonation	41700000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	244400000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	112700000
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	14600000
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	15300000
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	10200000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.017
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.038
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.009
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.013
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.004
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.014
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.60
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.775
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.575
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.60
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.50
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.62
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y10M24D
CY2022	gdrx	Dividends Received From Subsidiary DividendsReceivedFromSubsidiary	0
CY2021	gdrx	Dividends Received From Subsidiary DividendsReceivedFromSubsidiary	0
CY2020	gdrx	Dividends Received From Subsidiary DividendsReceivedFromSubsidiary	0

Files In Submission

Name	View Source	Status
gdrx-20221231_lab.xml	Edgar Link	unprocessable
0000950170-23-005262-index-headers.html	Edgar Link	pending
0000950170-23-005262-index.html	Edgar Link	pending
0000950170-23-005262.txt	Edgar Link	pending
0000950170-23-005262-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gdrx-20221231.htm	Edgar Link	pending
gdrx-20221231.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
gdrx-20221231_cal.xml	Edgar Link	unprocessable
gdrx-20221231_def.xml	Edgar Link	unprocessable
gdrx-20221231_htm.xml	Edgar Link	completed
gdrx-ex10_19.htm	Edgar Link	pending
gdrx-ex21_1.htm	Edgar Link	pending
gdrx-ex23_1.htm	Edgar Link	pending
gdrx-ex31_1.htm	Edgar Link	pending
gdrx-ex31_2.htm	Edgar Link	pending
gdrx-ex31_3.htm	Edgar Link	pending
gdrx-ex32_1.htm	Edgar Link	pending
gdrx-ex32_2.htm	Edgar Link	pending
gdrx-ex32_3.htm	Edgar Link	pending
img202313726_0.jpg	Edgar Link	pending
img95955175_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
gdrx-20221231_pre.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GDRX
GoodRx Holdings, Inc. Stock $gdrx

2022 Q4 Form 10-K Financial Statement

#000095017023005262 Filed on March 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GDRX GoodRx Holdings, Inc. Stock $gdrx

2022 Q4 Form 10-K Financial Statement

#000095017023005262 Filed on March 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GDRX
GoodRx Holdings, Inc. Stock $gdrx